AlphaLISA Human PD-1/PD-L2 Binding Kit, 500 Assay Points | PerkinElmer
PathPlus™ PD-L2 / PDCD1LG2 / CD273 Monoclonal Antibody Mouse | LSBio
Recombinant Human PD-L2 protein (Active) (ab283481) | Abcam
PD-L2 / PDCD1LG2 / CD273 - Clone PDL2/1850 | 80380
PD-L2 Detection Set - Cat. No. RF16020 | ProSci
JAK-STAT pathway deregulation and regulation of PDL1 and PDL2... | Download Scientific Diagram
Recognition of PDL1/L2 by different induced-fit mechanisms of PD1: a comparative study of molecular dynamics simulations - Physical Chemistry Chemical Physics (RSC Publishing)
Regulation of T cell activation and tolerance by PDL2 | PNAS
Anti-PDL2 Antibody | PDL2 Antibody | PDL2| ABM3D6.1G2 | PDCD1LG2| 10-7631
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy | Journal for ImmunoTherapy of Cancer
PD-L1 and PD-L2 Bind to PD-1 to Inhibit T Cell Activation | Bio-Techne
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer? - ScienceDirect
Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy | British Journal of Cancer
Evolving landscape of PD-L2: bring new light to checkpoint immunotherapy | British Journal of Cancer
PD-1:PD-L2 Cell-Based Inhibitor Screening Assay Kit
PD-1/PD-L1+PD-L2 signaling pathway. PD-1, programmed death receptor 1;... | Download Scientific Diagram
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4+ T Cell Immunity - ScienceDirect
Frontiers | The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
AlphaLISA Human PD-1/PD-L2 Binding Kit, 500 Assay Points | PerkinElmer
Human PD-L2/B7-DC Antibody AF1224: R&D Systems
PD-L2: A Viable Prognostic Biomarker in Prostate Cancer – Consult QD
Frontiers | The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
PDL2 monoclonal antibody (7C7) - ENZ-ABS697 - Enzo Life Sciences
Pharmaceuticals | Free Full-Text | The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia
